A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
An Open-Label, Comparative Study of the Effect of Sirolimus Versus Standard Treatment on Clinical Outcomes and Histologic Progression of Allograft Nephropathy in High Risk Pediatric Renal Transplant Patients
Sponsor: Boston Children's Hospital
Terminated
Inability to meet the accrual target of 213.
Other terminated trials from Boston Children's Hospital
Other End-Stage Renal Disease trials with similar outcome
A PHASE3 clinical study on End-Stage Renal Disease and Kidney Transplantation, this trial is terminated or withdrawn. The trial is conducted by Boston Children's Hospital and has accumulated 7 data snapshots since 1999. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Terminated PHASE3
-
Jun 2018 — Sep 2020 [monthly]
Terminated PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
Jul 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .